We're proud to announce that Dori Sarkis and Pamela Whitcomb will be representing Alcanza Clinical Research at the Alzheimer's Association International Conference (AAIC) this year! If you're interested in networking and learning more about our work in the Alzheimer's space, we'd love to connect. Please email Dori at [email protected] to set up a meeting. See you at AAIC!
Alcanza Clinical Research’s Post
More Relevant Posts
-
Join us for a recap of this year's World Parkinson's Congress from the perspective of those with YOPD! YOPN Board Member, Robert Cochrane, and several YOPN members will share their key takeaways, "Ah-ha" moments, and experiences from this event. They will also share specific learnings around topics and issues most relevant to our community. Register at: https://lnkd.in/eWyEe74h The World Parkinson's Congress provides an international forum for basic scientists, clinical researchers, health care professionals, people with Parkinson's and others to come together under one roof to discuss, learn, and engage in debate around the latest scientific discoveries, medical and comprehensive care practices related to Parkinson's disease.
-
-
Join us for a recap of this year's World Parkinson's Congress from the perspective of those with YOPD! YOPN Board Member, Robert Cochrane, and several YOPN members will share their key takeaways, "Ah-ha" moments, and experiences from this event. They will also share specific learnings around topics and issues most relevant to our community. Register at: https://lnkd.in/eWyEe74h The World Parkinson's Congress provides an international forum for basic scientists, clinical researchers, health care professionals, people with Parkinson's and others to come together under one roof to discuss, learn, and engage in debate around the latest scientific discoveries, medical and comprehensive care practices related to Parkinson's disease.
-
-
Past President Argentine Lipid Society. Internal Medicine physician and Lipidologist. Pharmacology Professor at FASTA University, School of Medicine.
👉2️⃣0️⃣1️⃣5️⃣, International Atherosclerosis Society (IAS) meeting in #amsterdan 😯My first poster about Lp(a) 5️⃣ patients with very high levels of Lp(a) and different clinical manifestations 💪It is fantastic to see today, 8️⃣years later, many presentations and how science has advanced
-
-
📆Save the date! Vincent Keunen, Andaman7’s CEO, will present at the 'Patient Mediated Research - This Is Really Different' session at EUCROF24. The 2024 event, which is now in its 7th year, aims to shape the future of Clinical Research in Europe. Book here: https://bit.ly/EC24Booking
-
-
Epidemiologist at NordicRWE | Leading Industry-Based Projects with Real World Data | PhD in Biochemistry | 39 Publications, 1800 Citations, H-index 21 | Open to New Opportunities
🌟 Don't miss the Norway Life Science 2024 Conference highlighting the crucial role of health data! NordicRWE pioneers big data-driven research in the Nordics. Let's drive healthcare innovation from afar! #Norwaylifescience2024 #healthdata #bigdata #NordicRWE
🌟Next week, on the 13th and 14th of February, the University of Oslo hosts the Norway Life Science 2024 Conference, themed "Unlocking the Potential of Health Data." We at NordicRWE are thrilled to see real-world data and evidence (#RWD #RWE) taking center stage at this year's conference. 🌟 🔹 On Stage Appearances: NordicRWE will feature prominently at the conference, contributing our expertise in several key sessions: Steinar Thoresen, our Medical Director, will give a speech in the main program on Day 1, discussing "Health data as a national resource: From research and value creation to legal barriers." Steinar will also share his insights as a panelist on Day 2, further delving into the critical role of health data. Christian Jonasson, our Research Director, is set to enlighten audiences with his speech and panel participation on Day 2’s afternoon session. The topic of his speech will be on " Health data for next generation trials," a topic of immense importance for advancing medical research and patient care. 👀 See You There: We're looking forward to engaging discussions, new insights, and the opportunity to connect with fellow colleagues in the field. Please reach out to us in case you want to connect and exchange ideas with us while at the conference. Website: www.nordicrwe.com e-mail: [email protected] Universitetet i Oslo Legemiddelindustrien (LMI) Oslo Cancer Cluster
-
Join Alzheimer's Association® Chief Science Officer, Maria C. Carrillo, Ph.D., who will present cutting-edge science from this year's Alzheimer’s Association International Conference® (AAIC®) and share insights on the most pressing healthcare issues of our time. Bring your questions for the Q&A session. Advances in Research: A New Era in Treatment is September 7, 2023 at 2 p.m. ET/1 p.m. CT. Save your spot today. Go to https://bit.ly/ALZNewEra23
-
-
WHO/Europe has been pleased to endorse this year’s European ME Alliance’s Invest in ME Research International ME Conference week, which came to a conclusion today. See WHO/Europe's conference address here: https://bit.ly/3XJiRDT Researchers, clinicians and patients met to discuss collaborative biomedical research projects essential to identify diagnostic biomarkers and curative treatments for people suffering from myalgic encephalomyelitis (ME) (also known as ME/CFS), a physical neurological illness first recognized by WHO in 1969. We know that research and treatments will take time, even years, to develop and implement, and in the meantime, governments must address the urgent ethical question of how to provide assistance today to ME/CFS patients with ‘invisible’ or ‘medically unexplained symptoms’, both to respect their basic human rights and their rights under the UN Convention on the Rights of Persons with Disabilities. Find out more about the EMEA: https://bit.ly/3VBBCGE Learn more about the Invest in ME Research Conference Week: https://bit.ly/4eGLA2o Gracemarie Bricalli (EMEA) European Federation of Neurological Associations
-
-
📆Save the date! Vincent Keunen, Andaman7’s CEO, will present at the 'Patient Mediated Research - This Is Really Different' session at EUCROF24. The 2024 event, which is now in its 7th year, aims to shape the future of Clinical Research in Europe. Book here: https://bit.ly/EC24Booking
-
-
Ludwig Boltzmann Institute for Traumatology, The Research Centre in Cooperation with AUVA
The very 👉 FIRST global World Sepsis Day (WSD) 👈 was inaugurated on September 13, 2012 by Global Sepsis Alliance (www.sepsis.org) and it continues ever since! WSD increases awareness 📣 on this life-threatening disease ☠ among medical personnel and lay people alike. Our 👉 LBI Traumatology has been researching sepsis for many years contributing to the understanding of its pathophysiology and phenotypes. 👍 ⛑ 👨⚕️ 🔬 One of the most prominent examples of our sepsis-oriented works are the so called MQTiPSS - Minimum Quality Threshold in Pre-Clinical Sepsis Studies - an International Expert Consensus Initiative for Improvement of Animal Modeling in Sepsis Research. This was accomplished within the Wiggers-Bernard Conference Initiative organized in Vienna in 2017 (https://lnkd.in/dnygu4C2). We have currently 3 ongoing sepsis-oriented research projects; the most spectacular and recent one is collaborative BEATSepsis funded by the EU. We really hope we can make a difference in combating sepsis! 🤞
Today is #WorldSepsisDay! Our Sepsis-Trauma-Shock group led by Marcin Osuchowski is working hard to improve the diagnosis, treatment and understanding of sepsis and we are proud to be part of BEATsepsis, the international consortium for sepsis survivorship, funded by Horizon Europe. Find out more: https://www.beatsepsis.eu/ Our consortium Partners: FricLab St. Anne's University Hospital Brno University of Galway Universitätsklinikum Bonn BioVariance GmbH CIML Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava APHM (Assistance Publique - Hopitaux de Marseille)
-
-
Senior Development Manager / Niceville-Valparaiso Rotary Club / Survivor / Community
Join Alzheimer's Association Chief Science Officer, Maria C. Carrillo, Ph.D., who will present cutting-edge science from this year's Alzheimer’s Association International Conference® (AAIC®) and share insights on the most pressing healthcare issues of our time. Bring your questions for the Q&A session. Advances in Research: A New Era in Treatment is September 7, 2023 at 2 p.m. ET/1 p.m. CT. Save your spot today. Go to https://bit.ly/ALZNewEra23
-
